Health / Medical Topics

    Myelodysplastic Syndromes

    Your bone marrow is the spongy tissue inside some of your bones, such as your hip and thigh bones. It contains immature cells, called stem cells. The stem cells can develop into the red blood cells that carry oxygen through your body, the white blood cells that fight infections, and the platelets that help with blood clotting. If you have a myelodysplastic syndrome, the stem cells do not mature into healthy blood cells. Many of them die in the bone marrow. This means that you do not have enough healthy cells, which can lead to infection, anemia, or easy bleeding.

    Myelodysplastic syndromes often do not cause early symptoms and are sometimes found during a routine blood test. If you have symptoms, they may include

    • Shortness of breath
    Weakness or feeling tired
    Skin that is paler than usual
    • Easy bruising or bleeding
    • Pinpoint spots under the skin caused by bleeding
    Fever or frequent infections

    Myelodysplastic syndromes are rare. People at higher risk are over 60, have had chemotherapy or radiation therapy, or have been exposed to certain chemicals. Treatment options include transfusions, drug therapy, chemotherapy, and blood or bone marrow stem cell transplants. (NIH National Cancer Institute)




    YOU MAY ALSO LIKE

    A myelodysplastic syndrome characterized by neutropenia or thrombocytopenia and dysplasia restricted to neutrophil or megakaryocytic cell lines. The blasts in the…
    A myelodysplastic syndrome characterized by a deletion between bands q31 and 33 on chromosome 5. The number of blasts in the…
    A myelodysplastic syndrome characterized by the presence of a point mutation in one of the following genes, TP53, EZH2, ETV6, RUNX1, and…
    Myelodysplastic syndrome 2 translocation-associated protein (140 aa, ~15 kDa) is encoded by the human MDS2 gene. This protein plays a role in…
    A type of cancer in which the bone marrow does not make enough healthy blood cells (white blood cells, red blood cells,…
    Abnormal bone marrow cells that may lead to myelogenous leukemia.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact